Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: European Academy of Allergy Asthma and Immunology (EAACI)
Wrongly Labeled: Challenges and Ways Forward in Food Allergen Labeling
News Wire ~ 3rd Party Press Release
-
2020/10/27
What must be done to improve allergen labeling.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
News Wire ~ 3rd Party Press Release
-
2019/06/05
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...
Dave Bloom
-
2019/06/03
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...
News Wire ~ 3rd Party Press Release
-
2019/03/25
Company Intends to Submit European MAA in Mid-2019.
Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...
Dave Bloom
-
2018/05/29
Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.